Enovis is a global medical technology company focused on advancing the field of musculoskeletal health. Formed through the separation of the MedTech business from Colfax Corporation in 2021, Enovis brings together a portfolio of specialized products and services designed to address conditions affecting the foot and ankle, hand and wrist, sports medicine, joint repair, biologics and rehabilitation.
The company’s flagship offerings include minimally invasive implants and instrumentation for foot and ankle surgery under the Treace Medical Concepts brand, focal joint resurfacing implants through Arthrosurface, and synthetic bone graft substitutes marketed as NovaBone. Enovis also provides orthobiologic solutions and surgical accessories via EBI, as well as custom and off-the-shelf orthotic braces and supports through its SmartStep and LITOS product lines.
Enovis serves surgeons, hospitals and rehabilitation specialists across North America, Europe and select Asia-Pacific regions, leveraging an integrated commercial network of direct sales teams and distribution partners. The company invests in clinical research and training programs to support product adoption, surgical education and patient outcomes.
Headquartered in Pittsburgh, Pennsylvania, Enovis is led by an executive team with extensive experience in medical device innovation and global market development. The company remains committed to expanding its portfolio through targeted acquisitions and continued R&D aimed at improving functional recovery and quality of life for patients worldwide.
AI Generated. May Contain Errors.
